Part:BBa_K3140000
PsiD - Tryptophan decarboxylase from Psilocybe cubensis
PsiD is a tryptophan decarboxylase that catalyses the conversion of L-tryptophan to tryptamine.
- NCBI: ASU62239.1
- UniProt: P0DPA6
- EC number: 4.1.1.105
Usage and Biology
The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
PsiD is a native enzyme obtained from the Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both L-tryptophan and 4-hydroxy-L-tryptophan as substrates, producing tryptamine (Fig. 1) and 4-hydroxytryptamine (Fig. 2), respectively. In a native state, PsiD is a 439 amino acid protein (49.6 kDa) with a theoretical pI of 5.44 calculated with the ExPASy ProtParam tool[2].
Heterologous expression of PsiD has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa.
A band consistent with expression of PsiD in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 4).
Activity of PsiD was confirmed with LC/MS. Protein extract from E. coli BL21(DE3) cells co-transformed with pET-28c(+):PsiD and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, tryptophan. The PsiD product, tryptamine, was only identified in the sample to which tryptophan was added, confirming the activity of PsiD in vitro (Fig. 5).
The presence of tryptophan in sample to which tryptophan was added may indicate autoxidation of tryptamine, as this compound was also observed in the mass spectrum of a 1 mM tryptamine standard (Table 1). However, neither hydroxytryptamine nor tryptamine was not observed in the sample to which tryptophan was not added (Table 2).
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
3.67 | 5.3 | 177.1023 | C10H13N2O | hydroxytryptamine |
4.91 | 16.6 | 205.0973 | C11H13N2O2 | tryptophan |
5.39 | 17.8 | 161.1074 | C10H13N2 | tryptamine |
10.12 | 9.6 | 285.1336 | C14H21O6 | unknown |
10.12 | 9.6 | 285.1336 | C9H18N8OP | unknown |
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
10.12 | 9.6 | 285.1336 | C14H21O6 | unknown |
10.12 | 9.6 | 285.1336 | C9H18N8OP | unknown |
In vivo expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 6). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
0.56 | 23.2 | 271.0817 | C12H15O7 | unknown |
1.16 | 12.4 | 257.0689 | C10H14N2O4P | norbaeocystin |
1.9 | 0.9 | 271.0844 | C11H16N2O4P | baeocystin |
2.75 | 5.2 | 177.1023 | C10H13N2O | hydroxytryptamine |
5.08 | 6.4 | 205.0972 | C11H13N2O2 | tryptophan |
5.82 | 6.4 | 161.1074 | C10H13N2 | tryptamine |
10.15 | 14.4 | 285.1335 | C14H21O6 | unknown |
10.15 | 14.4 | 285.1335 | C9H18N8OP | unknown |
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
None |